InspireMD targets $13M–$15M in 2026 revenue as CGuard Prime gains U.S. traction [Seeking Alpha]
InspireMD Inc. (NSPR)
NASDAQ:AMEX Investor Relations:
inspiremd.com/en/investors/investor-relations
Company Research
Source: Seeking Alpha
Marvin Slosman, President and CEO, emphasized InspireMD's momentum in stroke prevention, stating, "I'm extremely proud of our team here at InspireMD and enthusiastic about the impact we are having on stroke prevention and the future Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Quick Insights Projected U.S. revenue growth is driven by label expansion, enhanced product performance, and the pending FDA approval for CGuard Prime's use in TCAR and CAS procedures, as well as ongoing commercial team investment and operational scaling. Main risks include reliance on FDA approvals for expanded indications, elevated operating expenses from ongoing commercial and marketing investments, dependence on milestone-based financing, and execution risk in scaling from controlled to broader rollout. The strategy is shifting from controlled launch to deliberate scaling with a larger
Show less
Read more
Impact Snapshot
Event Time:
NSPR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NSPR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NSPR alerts
High impacting InspireMD Inc. news events
Weekly update
A roundup of the hottest topics
NSPR
News
- InspireMD Inc (NSPR) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advancements [Yahoo! Finance]Yahoo! Finance
- InspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- InspireMD Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
NSPR
Earnings
- 3/18/26 - Beat
NSPR
Sec Filings
- 3/18/26 - Form 10-K
- 3/18/26 - Form 8-K
- 3/4/26 - Form 8-K
- NSPR's page on the SEC website